Using the web-based eBioPortal and Xena, we found that HOXC8 is highly expressed in NSCLC (both LUAD and LUSC), and high HOXC8 expression is correlated with poorer survival in LUAD patients. The gene discussed is HOXC8; the disease is non-small cell lung carcinoma.